Targeting of neuroinflammation by glibenclamide in Covid-19: old weapon from arsenal

GES Batiha, HM Al-Kuraishy, AI Al-Gareeb… - …, 2023 - Springer
Abstract In coronavirus disease 2019 (Covid-19) era, neuroinflammation may develop due
to neuronal tropism of severe acute respiratory syndrome coronavirus type 2 (SARS-CoV-2) …

Monoamine oxidase inhibitors: A concise review with special emphasis on structure activity relationship studies

A Kumar, M Bhatia, A Kapoor, P Kumar… - European Journal of …, 2022 - Elsevier
Monoamine oxidase enzyme is necessary for the management of brain functions. It
oxidatively metabolizes monoamines and produces ammonia, aldehyde and hydrogen …

Introduction of benzyloxy pharmacophore into aryl/heteroaryl chalcone motifs as a new class of monoamine oxidase B inhibitors

ST Sudevan, JM Oh, MA Abdelgawad… - Scientific reports, 2022 - nature.com
The inhibitory action of fifteen benzyloxy ortho/para-substituted chalcones (B1-B15) was
evaluated against human monoamine oxidases (hMAOs). All the molecules inhibited hMAO …

Development of bromo-and fluoro-based α, β-unsaturated ketones as highly potent MAO-B inhibitors for the treatment of Parkinson's disease

MA Abdelgawad, JM Oh, DGT Parambi, S Kumar… - Journal of Molecular …, 2022 - Elsevier
This study evaluated the synthesis of a dual series of bromo (CHB1–CHB4)-and fluoro
(CHF1–CHF4)-based α, β-unsaturated ketones and their inhibitory activities against …

Chalcone derivatives with a high potential as multifunctional antioxidant neuroprotectors

A Pérez-González, R Castañeda-Arriaga… - ACS …, 2022 - ACS Publications
A systematic, rational search for chalcone derivatives with multifunctional behavior has been
carried out, with the support of a computer-assisted protocol (CADMA-Chem). A total of 568 …

Halogenated coumarin–chalcones as multifunctional monoamine oxidase-B and butyrylcholinesterase inhibitors

NA Rehuman, JM Oh, LR Nath, A Khames… - ACS …, 2021 - ACS Publications
A series of halogenated coumarin–chalcones were synthesized, characterized, and their
inhibitory activities against monoamine oxidases (MAOs), acetylcholinesterase (AChE) …

Development of isopropyl-tailed chalcones as a new class of selective MAO-B inhibitors for the treatment of Parkinson's disorder

S Kumar, JM Oh, MA Abdelgawad, MAS Abourehab… - ACS …, 2023 - ACS Publications
Thirteen isopropyl chalcones (CA1–CA13) were synthesized and evaluated for their
inhibitory activity against monoamine oxidase (MAO). All compounds inhibited MAO-B more …

An ongoing journey of chalcone analogues as single and multi-target ligands in the field of Alzheimer's disease: A review with structural aspects

P Sharma, M Singh - Life Sciences, 2023 - Elsevier
Alzheimer's disease (AD) is a chronic and irreversible neurodegenerative disorder with
progressive dementia and cognitive impairment. AD poses severe health challenge in …

Trimethoxylated halogenated chalcones as dual inhibitors of MAO-B and BACE-1 for the treatment of neurodegenerative disorders

VP Koyiparambath, JM Oh, A Khames… - Pharmaceutics, 2021 - mdpi.com
Six halogenated trimethoxy chalcone derivatives (CH1–CH6) were synthesized and
spectrally characterized. The compounds were further evaluated for their inhibitory potential …

[HTML][HTML] A structural approach to investigate halogen substituted MAO-B inhibitors using QSAR modeling, molecular dynamics, and conceptual DFT analysis

N Maliyakkal, I Ahmad, S Kumar, ST Sudevan… - Journal of Saudi …, 2023 - Elsevier
Halogenated inhibitors showed robust, reversible, and selective monoamine oxidase-B
(MAO-B) inhibitory efficacy in candidates that were derived from them. Our team has …